The Enterprise Value as of June 2026 (TTM) for Bright Minds Biosciences Inc. (DRUG) is 352.86M

According to Bright Minds Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 352.86M. This represents a change of -34.60% compared to the average of 539.55M of the last 4 quarters.

Bright Minds Biosciences Inc. (DRUG) Historical Enterprise Value (quarterly & annually)

How has DRUG Enterprise Value performed in the past?

The mean historical Enterprise Value of Bright Minds Biosciences Inc. over the last ten years is 97.03M. The current 352.86M Enterprise Value has changed 36.27% with respect to the historical average. Over the past ten years (40 quarters), DRUG's Enterprise Value was at its highest in in the December 2025 quarter at 768.14M. The Enterprise Value was at its lowest in in the June 2024 quarter at -16132.94.

Bright Minds Biosciences Inc. (DRUG) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bright Minds Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bright Minds Biosciences Inc. (DRUG) Average Enterprise Value

How has DRUG Enterprise Value performed in the past?

The current Enterprise Value of Bright Minds Biosciences Inc. (DRUG) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Bright Minds Biosciences Inc. (DRUG) Enterprise Value vs. Peers

How is DRUG’s Enterprise Value compared to its peers?

Bright Minds Biosciences Inc.’s Enterprise Value is less than LB Pharmaceuticals Inc Common Stock (497.78M), less than Design Therapeutics, Inc. (675.12M), greater than Aura Biosciences, Inc. (343.72M), greater than enGene Holdings Inc. (79.79M), greater than DiaMedica Therapeutics Inc. (299.78M), less than I-Mab (1.13B), greater than Altimmune, Inc. (168.60M), less than Annexon, Inc. (413.52M), greater than Galectin Therapeutics Inc. (297.44M), greater than Korro Bio, Inc. (96.75M),

Build a custom stock screener for Bright Minds Biosciences Inc. (DRUG) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bright Minds Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bright Minds Biosciences Inc. (DRUG) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bright Minds Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.